Cargando…

1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousaf, Anna R, Lindsey, Katherine N, Shah, Ami B, Miller, Allison D, Wu, Michael J, Melgar, Michael, Zambrano, Laura D, Campbell, Angela P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676941/
http://dx.doi.org/10.1093/ofid/ofad500.067
_version_ 1785150012672442368
author Yousaf, Anna R
Lindsey, Katherine N
Shah, Ami B
Miller, Allison D
Wu, Michael J
Melgar, Michael
Zambrano, Laura D
Campbell, Angela P
author_facet Yousaf, Anna R
Lindsey, Katherine N
Shah, Ami B
Miller, Allison D
Wu, Michael J
Melgar, Michael
Zambrano, Laura D
Campbell, Angela P
author_sort Yousaf, Anna R
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor outcomes and potentially inform treatment decisions. METHODS: This investigation included all MIS-C cases with known outcome reported to CDC MIS-C national surveillance from February 2020─December 2022. Clinical and demographic characteristics were compared between survivors and decedents. Decedents were described over time and classified by date of MIS-C illness onset into five pandemic waves corresponding to five peaks of MIS-C activity (Figure 1): (1) 2/19/2020─6/28/2020, (2) 6/29/2020─10/17/2020, (3) 10/18/2020─7/8/2021, (4) 7/9/2021─12/7/ 2021, and (5) 12/8/2021─12/31/2022. Waves 4 and 5 were periods of predominant Delta and Omicron SARS-CoV-2 variant circulation, respectively. [Figure: see text] RESULTS: Seventy-six decedents and 8,691 survivors were reported (Table). A higher proportion of decedents compared with survivors were aged 16-20 years (41% vs 9%; p< 0.01), from the South (55% vs 41%; p=0.01) and had MIS-C illness onset in wave 1 (18% vs 7%; p< .01). Half (51%) of decedents had an underlying medical condition compared with 24% of survivors (p< 0.01). A higher proportion of decedents than survivors had severe cardiovascular (95% vs 76%), respiratory (99% vs 36%), renal (59% vs 19%), and neurologic (30% vs 4%) involvement, and fewer had mucocutaneous (33% vs 75%). Deaths in the 16-20 age group were predominant in waves 1-4 but comprised only 15% of deaths in wave 5, when 57% of decedents were aged 0-4 years (Figure 2). Race and ethnicity of decedents varied over time. Severe cardiovascular and respiratory involvement was high ( >85-100%) over time in decedents; other organ manifestations varied by MIS-C wave. [Figure: see text] [Figure: see text] CONCLUSION: Older age (16-20 years), residing in the South, illness early in the pandemic, underlying medical conditions, and severe organ involvement were all significantly associated with death among children with MIS-C. MIS-C decedent characteristics are dynamic and may continue to evolve with changes in underlying population immunity, SARS-CoV-2 transmission, and variant emergence. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10676941
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106769412023-11-27 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022 Yousaf, Anna R Lindsey, Katherine N Shah, Ami B Miller, Allison D Wu, Michael J Melgar, Michael Zambrano, Laura D Campbell, Angela P Open Forum Infect Dis Abstract BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2. Identifying clinical and demographic characteristics associated with MIS-C mortality and description of MIS-C decedents over time may help identify children at increased risk for poor outcomes and potentially inform treatment decisions. METHODS: This investigation included all MIS-C cases with known outcome reported to CDC MIS-C national surveillance from February 2020─December 2022. Clinical and demographic characteristics were compared between survivors and decedents. Decedents were described over time and classified by date of MIS-C illness onset into five pandemic waves corresponding to five peaks of MIS-C activity (Figure 1): (1) 2/19/2020─6/28/2020, (2) 6/29/2020─10/17/2020, (3) 10/18/2020─7/8/2021, (4) 7/9/2021─12/7/ 2021, and (5) 12/8/2021─12/31/2022. Waves 4 and 5 were periods of predominant Delta and Omicron SARS-CoV-2 variant circulation, respectively. [Figure: see text] RESULTS: Seventy-six decedents and 8,691 survivors were reported (Table). A higher proportion of decedents compared with survivors were aged 16-20 years (41% vs 9%; p< 0.01), from the South (55% vs 41%; p=0.01) and had MIS-C illness onset in wave 1 (18% vs 7%; p< .01). Half (51%) of decedents had an underlying medical condition compared with 24% of survivors (p< 0.01). A higher proportion of decedents than survivors had severe cardiovascular (95% vs 76%), respiratory (99% vs 36%), renal (59% vs 19%), and neurologic (30% vs 4%) involvement, and fewer had mucocutaneous (33% vs 75%). Deaths in the 16-20 age group were predominant in waves 1-4 but comprised only 15% of deaths in wave 5, when 57% of decedents were aged 0-4 years (Figure 2). Race and ethnicity of decedents varied over time. Severe cardiovascular and respiratory involvement was high ( >85-100%) over time in decedents; other organ manifestations varied by MIS-C wave. [Figure: see text] [Figure: see text] CONCLUSION: Older age (16-20 years), residing in the South, illness early in the pandemic, underlying medical conditions, and severe organ involvement were all significantly associated with death among children with MIS-C. MIS-C decedent characteristics are dynamic and may continue to evolve with changes in underlying population immunity, SARS-CoV-2 transmission, and variant emergence. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10676941/ http://dx.doi.org/10.1093/ofid/ofad500.067 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Yousaf, Anna R
Lindsey, Katherine N
Shah, Ami B
Miller, Allison D
Wu, Michael J
Melgar, Michael
Zambrano, Laura D
Campbell, Angela P
1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title_full 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title_fullStr 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title_full_unstemmed 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title_short 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic—CDC National Surveillance, February 2020-December 2022
title_sort 1094. comparison of demographic and clinical characteristics in survivors vs. decedents with multisystem inflammatory syndrome in children (mis-c) during the covid-19 pandemic—cdc national surveillance, february 2020-december 2022
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676941/
http://dx.doi.org/10.1093/ofid/ofad500.067
work_keys_str_mv AT yousafannar 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT lindseykatherinen 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT shahamib 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT millerallisond 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT wumichaelj 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT melgarmichael 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT zambranolaurad 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022
AT campbellangelap 1094comparisonofdemographicandclinicalcharacteristicsinsurvivorsvsdecedentswithmultisysteminflammatorysyndromeinchildrenmiscduringthecovid19pandemiccdcnationalsurveillancefebruary2020december2022